Therapeutic Iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo-Trial): a prospective, randomized, multicenter phase II study [post]

2019 unpublished
doi:10.21203/rs.2.13712/v1 fatcat:yp7opr6fefbbde6slc3bfcczfi